임상시험

Stratagen Quantitative Prostate MRI Platform Pilot Study

NCT: NCT06985238 · ACTIVE_NOT_RECRUITING

NCT IDNCT06985238

상태ACTIVE_NOT_RECRUITING

시작일2025-09-24

완료2027-05-30

SponsorStratagen Bio, Inc. (INDUSTRY)

First posted2025-05-22

Last updated2026-10-09

간략 요약

The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions. * What severe problems, if any, occur because of the use of the Stratagen Quantitative Prostate MRI Platform? * Can the data collected be used to measure quantitative MRI parameters? Participants will: \- Receive up to 15 minutes of additional MRI scan time during the existing prostate MRI imaging session.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.